Slide 1: Annual and Q4 2025 Earnings Call
Annual and Q4 2025 Earnings Call March 5, 2026
Slide 2: Cautionary Statements
Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe
Slide 3: Highlights and Growth Momentum
Highlights and Growth Momentum Puneet Khanna President & Chief Executive Officer
Slide 4: Q4 and Full Year 2025
Q4 and Full Year 2025 Q4 2025 Average Beds Serviced1 92,250 +4,592 Revenue $96.1 million $370.2 million Adjusted EBITDA1 $8.8 million $32.9 million Adjusted EBITDA Margin1 9.2% 8.9% Net Income $1.0 million* $3.3 million* * After adjusting for $22.8 million income tax recovery 1. Adjusted EBITDA is a
Slide 5: 2025 Highlights
2025 Highlights • Ending Average Beds Serviced1 increased by 4,592 beds • Grew Adjusted EBITDA1 by 8.7% • Grew Adjusted EBITDA Margin1 63 basis points • Reduced Net Debt1 by 24% • Initiated quarterly dividend in Q3 2025 • Renewed Normal Course Issuer Bid • Hosted Ontario Minister of LTC at CareRx Oa
Slide 6: Operating and Financial Results
Operating and Financial Results Suzanne Brand Chief Financial Officer
Slide 7: Q4 2025 Financial Results
Q4 2025 Financial Results As at December 31, 2025 Year-over-year: Average Beds Serviced1 • Revenue increase was primarily driven by the 92,250 vs 87,658 in Q4 2024 increase in the number of Average Beds Revenue Serviced¹ $96.1 million vs $92.2 million in Q4 2024 • Adjusted EBITDA1 and Adjusted EBITD
Slide 8: 2025 Year-End Balance Sheet
2025 Year-End Balance Sheet As at December 31, 2025 Quarter-over-quarter: • Net Debt improved due to repayment of term Cash loan $13.9 million vs $15.5 million at Q3 2025 • Net Debt to Adjusted EBITDA1 improvement due to a decrease in Net Debt1 and increase Net Debt1 in run-rate Adjusted EBITDA1 $27
Slide 9: Final Perspectives
Final Perspectives Puneet Khanna President & Chief Executive Officer
Slide 10: Final Perspectives
Final Perspectives • Over 40,000 flu shots administered by CareRx pharmacists in Q4 2025 • Diabetes management study co-led by CareRx professionals, published in JMIR • Feature article in LTC Today Magazine on how pharmacy is helping shape the future of long-term care • Support for the Senior Living
Slide 11: Slide 11